The leading life sciences reagents and instruments company is expected to announce its fiscal second-quarter earnings for ...

Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...

Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it ...

Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday. Olin cut its fourth-quarter outlook, citing a slowdown in ...

"Thompson Street is pleased to support PestCo's continued expansion in the Houston metropolitan area through the acquisition of Bio-Tech, a well-established and respected player in the region," said ...

Ousted Venezuelan President Nicolás Maduro pleaded not guilty to narcotrafficking charges during his arraignment in U.S. federal court Monday, defiantly telling a judge that he was still the head of ...

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables ...

Shares of Bio-Techne Corp. rallied 5.67% to $63.03 Monday, on what proved to be an all-around favorable trading session for ...